Inventor
KOWARIK MICHAEL THOMAS
CH17 patents
⚠️ This page may combine multiple inventors who share the name “KOWARIK MICHAEL THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLAXOSMITHKLINE BIOLOGICALS SA
13 patentsUS11015177B2May 25, 2021
Compositions and methods for protein glycosylation
GLAXOSMITHKLINE BIOLOGICALS SA11 citations82
US10577592B2Mar 3, 2020
Compositions and methods for protein glycosylation
GLAXOSMITHKLINE BIOLOGICALS SA12 citations82
US10583185B2Mar 10, 2020
Methods and compositions for immune protection against extra-intestinal pathogenic E. coli
GLAXOSMITHKLINE BIOLOGICALS SA12 citations81
US10150952B2Dec 11, 2018
Compositions and methods for protein glycosylation
GLAXOSMITHKLINE BIOLOGICALS SA12 citations80
US12442019B2Oct 14, 2025
Process for the manipulation of nucleic acids
GLAXOSMITHKLINE BIOLOGICALS SA0 citations57
US12076385B2Sep 3, 2024
Methods and compositions for immune protection against extra-intestinal pathogenic E. coli
GLAXOSMITHKLINE BIOLOGICALS SA0 citations57
US11959092B2Apr 16, 2024
Process for the manipulation of nucleic acids
GLAXOSMITHKLINE BIOLOGICALS SA1 citations57
US11484582B2Nov 1, 2022
Methods and compositions for immune protection against extra-intestinal pathogenic E. coli
GLAXOSMITHKLINE BIOLOGICALS SA0 citations57
US12128096B2Oct 29, 2024
Immunogenic composition
GLAXOSMITHKLINE BIOLOGICALS SA0 citations56
US11376314B2Jul 5, 2022
Immunogenic composition
GLAXOSMITHKLINE BIOLOGICALS SA0 citations56
US11654190B2May 23, 2023
Immunogenic composition
GLAXOSMITHKLINE BIOLOGICALS SA0 citations45
US11406696B2Aug 9, 2022
P aeruginosa PcrV-linked antigen vaccines
GLAXOSMITHKLINE BIOLOGICALS SA0 citations43
US12559731B2Feb 24, 2026
Mutated PglB oligosaccharyl transferase enzymes
GLAXOSMITHKLINE BIOLOGICALS SA0 citations38
JANSSEN PHARMACEUTICALS INC
4 patentsUS11446370B2Sep 20, 2022
Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereof
JANSSEN PHARMACEUTICALS INC6 citations81
US12233121B2Feb 25, 2025
Methods of producing bioconjugates of E. coli O-antigen polysaccharides, compositions thereof, and methods of use thereof
JANSSEN PHARMACEUTICALS INC0 citations58
US11931405B2Mar 19, 2024
Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereof
JANSSEN PHARMACEUTICALS INC1 citations58
US11491220B2Nov 8, 2022
Methods of producing bioconjugates of E. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof
JANSSEN PHARMACEUTICALS INC0 citations58